Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

CNBC

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

EconomyDaily Composite
ShareXFacebook

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Seres on Impact of Middle East War
Bloomberg Markets

Seres on Impact of Middle East War

Seres Group President Jonn Zhang discusses how the company is managing risks to its overseas expansion plans, particularly in the Middle East. He speaks to Bloomberg's Stephen Engle at the Beijing Auto Show. (Source: Bloomberg)

Read more →
China's FAW on Modernization and Expansion Plans
Bloomberg Markets

China's FAW on Modernization and Expansion Plans

Giles Taylor, VP of Global Design & Chief Creative Officer at FAW Group, discusses the shakedown he expects in the auto sector as the Chinese state-owned carmaker seeks to modernize itself. He speaks to Bloomberg's Stephen Engle at the Beijing Auto Show. (Source: Bloomberg)

Read more →
Advertisement